ArticleCancer reports (Hoboken, N.J.)2022

A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of acute myeloid leukemia (AML).

Hidenori Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.